Young women took methylfolate, folic acid or a dummy pill; red cell folate rose most with 416 mcg of methylfolate.
Trial · 144 people · 24 weeks · funding not stated
Lamers et al., Am J Clin Nutr, 2006
Terms and sources
- Young women
- 144 healthy women aged 19 to 33, in Germany. Four groups: 416 or 208 mcg of [6S]-5-methyltetrahydrofolate, 400 mcg of folic acid, or a dummy pill, daily.
- methylfolate
- 416 mcg is the same molar amount as 400 mcg of folic acid. The abstract does not name the salt or the maker.
- a dummy pill
- Placebo; the abstract does not describe it. Double-blind.
- red cell folate rose most with 416 mcg of methylfolate
- Over 24 weeks, red cell folate rose more with 416 mcg of methylfolate than with folic acid or 208 mcg. The difference was statistically significant. It had not leveled off by week 24; plasma folate leveled off after 12 weeks. A second report of the same trial found that homocysteine fell about equally with all three supplements. Plasma folate rose less with 208 mcg of methylfolate than with folic acid or 416 mcg.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (University of Bonn, Germany).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
144 healthy women aged 19 to 33 took a daily supplement or a dummy pill for 24 weeks. The supplement was 416 or 208 mcg of methylfolate, or 400 mcg of folic acid. 416 mcg of methylfolate has the same folate as 400 mcg of folic acid. Red blood cell folate rose more with 416 mcg of methylfolate than with folic acid or the smaller methylfolate dose. The difference was statistically significant. Red cell folate had not leveled off by week 24. A second report of the trial found that homocysteine fell about equally in all three supplement groups. The trial measured blood folate, not health outcomes. Men were not studied. PubMed 16825690. Funding: we could not find who paid.
Adults took methylfolate, folic acid or a dummy pill for 24 weeks; homocysteine differed between forms, blood folate did not.
Trial · 167 people · 24 weeks · funding not stated
Venn et al., Am J Clin Nutr, 2003
Terms and sources
- Adults
- 167 healthy volunteers in New Zealand, living at home. Daily 113 mcg of L-methylfolate, 100 mcg of folic acid, or a dummy pill. EFSA (2022) notes that a 2002 report covers a subset of these participants.
- methylfolate
- 113 mcg is the same molar amount as 100 mcg of folic acid. The abstract does not name the salt or the maker.
- a dummy pill
- Placebo; the abstract does not describe it. Double-blind, as indexed in PubMed.
- homocysteine differed between forms
- After 24 weeks, homocysteine was 14.6% lower than with the dummy pill with methylfolate and 9.3% lower with folic acid. The difference between the two forms was statistically significant.
- blood folate did not
- With methylfolate, plasma folate was 34% higher than with the dummy pill; with folic acid, 52%. Red cell folate was 23% and 31% higher. The two forms did not differ significantly.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (University of Otago, New Zealand).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
167 healthy adults in New Zealand took a daily supplement or a dummy pill for 24 weeks. The supplement was 113 mcg of L-methylfolate or 100 mcg of folic acid. Both doses have the same folate. Compared with the dummy pill, homocysteine was 14.6% lower with methylfolate and 9.3% lower with folic acid. That difference between the forms was statistically significant. Plasma and red cell folate were higher in both groups and did not differ significantly between forms. The trial measured blood markers, not health outcomes. PubMed 12600857. Funding: we could not find who paid.
Adults ate wheat rolls with methylfolate, folic acid or neither for 16 weeks; blood folate did not differ between forms.
Trial · 45 people · 16 weeks · funding not stated
Green et al., J Nutr, 2013
Terms and sources
- Adults
- 45 healthy men and women aged 18 to 45. Double-blind.
- methylfolate
- 452 mcg a day of calcium L-5-methyltetrahydrofolate, the same molar amount as 400 mcg of folic acid. It was microencapsulated with sodium ascorbate, a form of vitamin C, and a modified starch. The abstract does not say whether the folic acid rolls had them too. The abstract does not name the maker.
- neither
- Placebo: rolls with no added folate.
- blood folate did not differ between forms
- At 16 weeks, red cell folate was 0.48 µmol/L higher after methylfolate than with plain rolls. After folic acid, it was 0.37 higher. Plasma folate was 23 nmol/L higher in both. The difference between forms was not statistically significant.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (University of British Columbia, Canada).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
45 healthy adults aged 18 to 45 ate wheat rolls daily for 16 weeks. The rolls had 452 mcg of microencapsulated methylfolate, 400 mcg of folic acid, or no added folate. Both forms have the same folate. Red cell and plasma folate were higher with both forms than with plain rolls. They did not differ significantly between forms. The trial measured blood folate, not health outcomes. PubMed 23616513. Funding: we could not find who paid.
Adults aged 50 to 65 took methylfolate or folic acid for 4 weeks; homocysteine changes did not differ.
Trial · 40 people · 4 weeks
Sicińska et al., Int J Food Sci Nutr, 2018
Terms and sources
- Adults aged 50 to 65
- 40 healthy volunteers with normal blood folate, in two groups. They had taken no B vitamin supplements for 6 months. PubMed indexes it as a randomized, double-blind trial.
- methylfolate
- [6S]-5-methyltetrahydrofolate, the same molar amount as 400 mcg of folic acid, daily. The abstract does not name the salt or who supplied it. There was no dummy group. Europe PMC lists a UK research council (BBSRC) and the EU as funders.
- homocysteine changes did not differ
- Homocysteine fell by 7.8% with methylfolate and 13.4% with folic acid. The fall within each group was statistically significant. The difference between forms was not.
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
40 healthy adults aged 50 to 65 took methylfolate or folic acid daily for 4 weeks. Both doses have the same folate as 400 mcg of folic acid. Homocysteine fell by 7.8% with methylfolate and 13.4% with folic acid. The difference between forms was not statistically significant. There was no dummy group. PubMed 28460586. Funding: Europe PMC lists the UK Biotechnology and Biological Sciences Research Council and the EU as funders.
Adults took methylfolate or folic acid daily for 5 weeks; test-dose absorption differed between forms in young adults only.
Trial · 24 people · 5 weeks
de Meer et al., Eur J Clin Nutr, 2005
Terms and sources
- Adults
- 24 healthy volunteers: 12 under 30 and 12 aged 50 or older. Double-blind.
- methylfolate
- [6S]-5-methyltetrahydrofolate, the same molar amount as 400 mcg of folic acid, daily. The abstract does not name the salt or who supplied it. The abstract names the European Union as the funder.
- test-dose absorption
- Absorption of an oral test dose of labeled folic acid, before and after the 5 weeks. The abstract does not give the test dose.
- in young adults only
- In the young, absorption fell by 22% after methylfolate and rose by 21% after folic acid. The difference was statistically significant. In the older group, no such changes were found.
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
24 healthy adults took methylfolate or folic acid daily for 5 weeks. 12 were under 30 and 12 were 50 or older. Both had the same folate as 400 mcg of folic acid. Absorption of a labeled folic acid test dose was measured before and after. In the young, it fell by 22% after methylfolate and rose by 21% after folic acid. The difference was statistically significant. No such changes were found in the older group. There was no dummy group. PubMed 16151461. Funding: the European Union, as the abstract states.
Women took one dose of methylfolate and one of folic acid, in random order; blood folate rose more after methylfolate.
Trial · 16 women with two copies of the MTHFR 677T variant and 8 with none · 8 hours after each dose · maker-funded
Prinz-Langenohl et al., Br J Pharmacol, 2009
Terms and sources
- Women
- 24 healthy women of childbearing age, recruited in Bonn, Germany. They were chosen by a common gene variant, MTHFR 677C>T: 16 with two copies, 8 with none. Double-blind.
- one dose of methylfolate
- 416 mcg of [6S]-5-methyltetrahydrofolate as Metafolin, its calcium salt, in a tablet. The same molar amount as the 400 mcg of folic acid.
- in random order
- Each woman took both, one after the other, 6 days apart. Each dose was taken with water after a 12-hour overnight fast.
- blood folate rose more after methylfolate
- Over 8 hours, plasma folate was higher and peaked sooner after methylfolate, in both gene groups. The difference was statistically significant. Plasma folate was mostly 5-MTHF after either form. Unconverted folic acid appeared in 18 of 24 women after folic acid and in 2 after methylfolate. A 2020 paper by Obeid et al. reanalyzed blood samples from 21 of these women.
- maker-funded
- Merck Selbstmedikation, Germany, supplied the Metafolin and paid for the trial. The authors report no conflicts of interest with the sponsor.
Study · Free full text · about 20 min to read
Our estimate at about 200 words a minute, from the full text on PubMed Central.
Study summary
24 healthy women took one dose of 416 mcg methylfolate and one of 400 mcg folic acid, in random order. The doses were 6 days apart, each after an overnight fast. 16 had two copies of a common MTHFR gene variant and 8 had none. Over 8 hours, plasma folate was higher and peaked sooner after methylfolate, in both groups. The difference was statistically significant. Unconverted folic acid appeared regularly after folic acid and rarely after methylfolate. Single doses only; men were not studied. PubMed 19917061. Funding: Merck Selbstmedikation, which supplied the methylfolate.
Men took single doses of methylfolate, folic acid and a dummy capsule in random order; folate responses did not differ.
Trial · 13 people · 10 hours after each dose · funding not stated
Pentieva et al., J Nutr, 2004
Terms and sources
- Men
- 13 healthy men in Northern Ireland. Double-blind. They were first "presaturated" with folic acid; the abstract does not give the dose or for how long.
- single doses of methylfolate
- 500 mcg of [6S]-5-methyltetrahydrofolate in a capsule. The abstract does not name the salt or the maker. EFSA (2022) lists the doses as taken with a meal.
- a dummy capsule
- Placebo capsule.
- in random order
- One dose a week, each man taking all three. The folic acid dose was also 500 mcg.
- folate responses did not differ
- The peak plasma folate response was 33.4 nmol/L after folic acid and 31.8 after methylfolate. The difference was not statistically significant. The area under the folate curve did not differ either.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (University of Ulster, Northern Ireland).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
13 healthy men took 500 mcg of methylfolate, 500 mcg of folic acid and a dummy capsule, in random order. Each was a single dose, one week apart. Beforehand they were presaturated with folic acid; the abstract does not give that dose. Over 10 hours, the peak plasma folate response did not differ between the two forms. Nor did the area under the folate curve. Both were higher than with the dummy capsule. Single doses only; women were not studied. PubMed 14988450. Funding: we could not find who paid.
Adults took single doses of methylfolate and folic acid in random order; blood methylfolate rose more after methylfolate.
Trial · 12 men and 12 women · 8 hours after each dose · industry-funded
Obeid et al., Nutrients, 2020
Terms and sources
- Adults
- 24 healthy adults aged 18 to 50 in Germany, 12 men and 12 women. Double-blind.
- methylfolate
- 436 mcg of the sodium salt of (6S)-5-methyltetrahydrofolate, Arcofolin, in a capsule. The same molar amount as the 400 mcg of folic acid.
- in random order
- Each took both, about 2 weeks apart, with water on an empty stomach.
- blood methylfolate rose more after methylfolate
- The area under the 8-hour plasma methylfolate curve was 126.0 after methylfolate and 56.0 after folic acid. Units are nmol/L×h. The difference was statistically significant. Total plasma folate was also higher. Unconverted folic acid appeared only after folic acid. The paper also reanalyzed samples from 21 women of the Prinz-Langenohl 2009 trial.
- industry-funded
- Merck & Cie, Switzerland, paid for this trial. Two of the eight authors worked there; the first author was an external consultant during the study. A Swiss pharmacy made the capsules.
Study · Free full text · about 30 min to read
Our estimate at about 200 words a minute, from the full text on PubMed Central.
Study summary
24 healthy adults took one dose of 436 mcg methylfolate sodium salt and one of 400 mcg folic acid. The order was random, and the doses were 2 weeks apart. Both have the same folate. Over 8 hours, plasma methylfolate was higher after methylfolate. The difference was statistically significant. Unconverted folic acid appeared only after folic acid. Single doses only. PubMed 33255787. Funding: Merck & Cie, Switzerland.
Women took 250 or 500 mcg folic acid or a dummy tablet for 4 weeks; homocysteine fell from the start.
Trial · 144 people · 4 weeks · funding not stated
Brouwer et al., Am J Clin Nutr, 1999
Terms and sources
- Women
- 144 healthy women aged 18 to 40, in the Netherlands, on their usual diet. Their food gave about 280 mcg of folate a day.
- 250 or 500 mcg folic acid
- 500 mcg every day, or 500 mcg every second day, which averages 250 mcg a day.
- a dummy tablet
- Placebo tablet.
- homocysteine fell from the start
- By 11.4% with 250 mcg (50 women) and 21.8% with 500 mcg (45 women), against the start of the trial. The abstract does not give the comparison with the dummy tablet. Plasma and red cell folate rose. 8 weeks after stopping, homocysteine had not returned to the starting level.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (Wageningen Agricultural University, Netherlands).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
144 healthy women aged 18 to 40 took folic acid or a dummy tablet for 4 weeks. One group took 500 mcg a day; another took 500 mcg every second day, about 250 mcg a day. Homocysteine fell from the start by 11.4% and 21.8%. Plasma and red cell folate rose. The abstract does not give the comparison with the dummy tablet. 8 weeks after stopping, homocysteine had not returned to the start. Men were not studied. PubMed 9925130. Funding: we could not find who paid.
Women took 750 mcg folate, vitamin B6, B12 or a dummy pill for 35 days; mood did not differ.
Trial · 211 women in four groups; group sizes are not in the abstract · 35 days · funding not stated
Bryan et al., J Nutr, 2002
Terms and sources
- Women
- 211 healthy younger, middle-aged and older women. The abstract does not give the age range.
- 750 mcg folate
- Daily. The abstract does not name the form. The other groups took 75 mg of vitamin B6 or 15 mcg of vitamin B12.
- a dummy pill
- Placebo; the abstract does not describe it.
- mood did not differ
- The authors report statistically significant higher scores on some memory tests with the vitamins. The abstract does not name which vitamin.
- funding not stated
- We could not read a funding section. PubMed lists an affiliation only for the first author (CSIRO Health Sciences and Nutrition, Adelaide).
Study · Abstract only · about 2 min to read
Our estimate for reading the abstract: 2 minutes.
Study summary
211 healthy women of various ages took a vitamin or a dummy pill daily for 35 days. The daily amounts were 750 mcg of folate, 15 mcg of vitamin B12 or 75 mg of vitamin B6. They did memory, thinking and mood tests before and after. Mood did not differ. The authors report statistically significant higher scores on some memory tests with the vitamins. The abstract does not name which. Men were not studied. PubMed 12042457. Funding: we could not find who paid.